After effective treatment, the tumor disappears, and the advanced non -small cell lung cancer is not "late" in advanced inning.

If you run the wrong direction from the beginning during the sports competition, it is useless to work harder.

The same is true on the road of anti -cancer. If the treatment is "biased", it will directly affect the patient's survival and quality of life.

Therefore, it is important to learn staging after diagnosis of lung cancer. It is important to take targeted treatment!

01

Local advanced lung cancer in the "seam" must be paid attention to

Some friends who look for lung cancer may only stay in the "early", "mid -term", "late stage", but in fact in clinical treatment, lung cancer staging is very "fine".

According to the eighth edition of international lung cancer TNM staging [1]:

Phase I (phase ⅠA, phase IB): The number of cancer cells is small, staying somewhere in the lungs, and not running everywhere.

Phase II (phase IIA, phase IIB): The number of cancer cells increased, and some were still restless and ran near the clung.

Phase III (phase III, ⅢB, IIIC): The number of cancer cells continues to increase, the more and the farther running, the vertical or extra -lung lymph nodes have their footprints.

Phase IV lung cancer (stage IV, IVB): The number of cancer cells soared, and began to not satisfy the lung system, running to the human body with the blood, such as bone, liver, and brain.

Did you find friends? Phase III is thinner! This clip is in the early and late stages, which are generally called late stage. Patients with non-small cell lung cancer generally have regional lymph node metastasis, but there is no distant metastase [2-3]. The following is the TMN staging of local advanced non -small cell lung cancer:

T represents tumors, M represents metastasis, n represents lymph nodes [1] III: T3N1, T4N0-1, T1-2N2 ⅢB stage: T1-2/N3, T3-4/N2 ⅢC stage: T3-4/n3

Some friends will think: "It's so embarrassing in the late stage, is it good or not surgery?"

Scientists think so too. Therefore, in order to help more patients find a suitable treatment plan, non-small cell lung cancer patients are divided into two categories: surgical and non-surgical according to various factors [2-3] according to various factors.

So in the process of clinical practice, which local advanced lung cancer patients can surgery, and what are the treatment programs for advanced lung cancer patients in advanced periods?

02

The later period is not late, experts live broadcast to help anti -cancer

In order to help more patients with lung cancer can grasp their staging, accept the treatment plan that suits them best, and truly maximize the opportunity to survive. Under the guidance of the Chinese Anti -Cancer Association Popular Science Professional Committee, Xunjian Lung Xiaofan opened it to find friends to find friends. In 2022, the thirteenth theme of the "Pulmonary Power" was the popular science live broadcast of "sticking to the line of defense! Reduce the recurrence and metastasis of lung cancer, and the later period is not late".

In this live broadcast, we are very honored to invite three lung cancer experts:

Professor Hu Chengping from the Department of Respiratory and Critical Medicine of Xiangya Hospital of Central South University;

Professor Hu Chunhong from the Cancer Center of Xiangya Second Hospital of Zhongnan University;

Professor Wang Hui from the Radiotherapy Center of Hunan Cancer Hospital.

Live theme

In this live broadcast, Professor Hu Chengping will explore the theme of how to delay the recurrence of lung cancer for friends; Professor Hu Chunhong will popularize the popularization of lung cancer diseases and diagnosis and treatment knowledge; Topic explanation.

Live information

Live broadcast time

September 26th 19: 00-21: 00

Live appointment

Methods: China Anti -Cancer Association ’s popular science public account“ Tumor Good Doctor ”public welfare science popularization channel, appointment to watch.

Expert Introduction

Professor Hu Chengping

Chief Physician of the Department of Respiratory and Critical Medicine of Xiangya Hospital of Central South University

Standing Committee Member of the China Anti -Cancer Association Lung Cancer Professional Committee

Director of Lung Cancer Diagnosis and Treatment Center of Xiangya Hospital of Central South University

Director of Hunan Province Respiratory Disease Quality Control Center

Standing Committee Member of the Chinese Medical Association Respiratory Disease Branch

Standing Committee Member of the Chinese Physician Association Breathing Physician Branch

The winner of the National 38 Red Banner, the Chinese Physician Award, and the Chinese Breathe Medicine Award

Professor Hu Chunhong

Chief Physician of the Cancer Center of Xiangya Second Hospital of Central South University

Deputy Chairman of the Hunan Anti -Cancer Association Lung Cancer Professional Committee

Deputy Chairman of the Professional Committee of Precision Medicine and Tumor Rehabilitation of China Rehabilitation Technology Transformation and Development Promotion Association

Standing Committee Member of the Chinese Research Hospital Society of Precision Medicine and Tumor MDT

Deputy Chairman of the Cancer Professional Committee of Hunan Sino -Western Society

Deputy Chairman of the Hunan Society of Pathology Society

Professor Wang Hui

Chief Physician of the Radible Treatment Center of Hunan Cancer Hospital

National May Day Labor Medal Laurether

Enjoy special allowance experts from the State Council

Direct health expert in Hunan Province

Chairman of the Hunan Anti -Cancer Association Radiotherapy Professional Committee

The Hunan Medical Association's Radiation Cancer Professional Committee

Deputy Chairman of the Hunan Medical Association Cancer Professional Committee

Standing Committee of the Chinese Physician Association Radious Tumor Tests Medicine Branch

China Research Hospital Society Deputy Chairman of Tumor Radiation Biological and Multimelical Diagnosis and Treatment Professional Committee

Standing Committee of the China Medical Promotion Council Radiation Oncology Branch

Source

; 11 (1): 39-51. [2] NCCN non-small cell lung cancer clinical practice guide 2022.v4

[3] CSCO non -small cell lung cancer diagnosis and treatment guide (2022)

- END -